Benepet's mission is to continuously improve the quality and efficiency of Veterinary clinical treatment.
“Better outcomes mean healthier pets and happier pet owners.”
Manhattan Veterinary Hospital
Benepet Biomedical Co., Ltd. was established in May 2017 for the purpose of providing innovative, high quality clinical products to veterinary practices and hospitals. Working together with Taiwan’s renowned Industrial Technology Research Institute and manufacturing partner Acer Inc., Benepet Biomedical has introduced the world's first fully automated peritoneal dialysis machine designed specifically for veterinary use. This award-winning, patented* design not only improves outcomes for pets requiring peritoneal dialysis but also significantly reduces the labor and cost of such treatments. In the future, the company plans to launch pharmaceuticals, nutritional products and additional medical devices for veterinary use. Benepet Biomedical is committed to addressing the clinical needs of veterinarians and improving the quality of veterinary health care through world-class R&D and the innovative application of leading-edge technology.
Pets need peritoneal dialysis?
Peritoneal dialysis is a therapeutic treatment that removes toxins from the bloodstream when a patient’s kidneys are not functioning normally. It is similar to hemodialysis, but employs a different method of achieving the same result. In peritoneal dialysis therapy, a dialysate solution is placed inside the patient’s abdominal cavity through a catheter, where it is allowed to dwell for a period of time during which toxins in the blood are gradually absorbed by the dialysate through the peritoneal membrane. The dialysate is then drained from the abdominal cavity and discarded. This process is typically repeated multiple times until the levels of toxins and fluids in the bloodstream have returned to healthy levels, and may continue on either a continual or intermittent basis until the patient has regained kidney function.